Talking O&G - a RANZCOG Podcast

E10. In Conversation with Endometriosis Expert A/Prof Mathew Leonardi (video)

In this episode of Talking O&G, host Dr Heather Waterfall is joined by Associate Professor Mathew Leonardi to answer RANZCOG members’ and trainees’ questions on endometriosis.

An internationally recognised leader in gynaecological surgery and ultrasound, Mathew is an Associate Professor at McMaster University Medical Centre in Hamilton, Canada, and holds a PhD from the University of Sydney. He sits on the World Endometriosis Society Early Career Board and is a founding member of the Next Generation Committee at the International Society of Ultrasound in Obstetrics and Gynaecology.

During the discussion, Mathew weighs in on the shift towards ultrasound as the preferred first-line diagnostic tool for endometriosis, the benefits and limitations of this method, how MRI compares, and recommendations for laparoscopy as a surgical intervention. Mathew also advocates for upskilling both gynaecologists and sonographers in advanced gynaecological ultrasound, the importance of ‘prehab’, and how to support patients with endometrioma who are seeking fertility.

🔗 Resources mentioned in this episode:

• Talking O&G E4. Unpacking RANZCOG’s New Endometriosis Guideline
• Australian Living Evidence Guideline: Endometriosis
• Patient resources: https://ranzcog.edu.au/womens-health/endometriosis/

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. 

In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.  

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

COI Statement: Mathew Leonardi reports grants from Australian MRFF, AbbVie, AIMA/SOPHIE, CanSAGE, CIHR, Endometriosis Australia, Hamilton Health Sciences, Health Canada, Hyivy/MITACS/SOPHIE, Medical Research Future Fund/Imagendo, Myant Inc/MITACS, GE HealthCare/MITACS, and Pfizer; honoraria for lectures/writing from AIUM, AbbVie, Bayer, Canon, GE Healthcare, Pfizer, Samsung, TerSera; consultancy work with AbbVie, Chugai, Gesynta, Hologic, Imagendo, Pfizer, and Roche Diagnostics; and affiliations with SUGO (Specialized Ultrasound in Gynecology & Obstetrics) and Endometriosis360. He holds leadership roles in the World Endometriosis Society Early Career Board, ISUOG Next Generation, and the Gynecologic Ultrasound Society, all outside the submitted work.

E10. In Conversation with Endometriosis Expert A/Prof Mathew Leonardi (audio)

In this episode of Talking O&G, host Dr Heather Waterfall is joined by Associate Professor Mathew Leonardi to answer RANZCOG members’ and trainees’ questions on endometriosis.

An internationally recognised leader in gynaecological surgery and ultrasound, Mathew is an Associate Professor at McMaster University Medical Centre in Hamilton, Canada, and holds a PhD from the University of Sydney. He sits on the World Endometriosis Society Early Career Board and is a founding member of the Next Generation Committee at the International Society of Ultrasound in Obstetrics and Gynaecology.

During the discussion, Mathew weighs in on the shift towards ultrasound as the preferred first-line diagnostic tool for endometriosis, the benefits and limitations of this method, how MRI compares, and recommendations for laparoscopy as a surgical intervention. Mathew also advocates for upskilling both gynaecologists and sonographers in advanced gynaecological ultrasound, the importance of ‘prehab’, and how to support patients with endometrioma who are seeking fertility.

🔗 Resources mentioned in this episode:

• Talking O&G E4. Unpacking RANZCOG’s New Endometriosis Guideline
• Australian Living Evidence Guideline: Endometriosis
• Patient resources: https://ranzcog.edu.au/womens-health/endometriosis/

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. 

In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.  

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

COI Statement: Mathew Leonardi reports grants from Australian MRFF, AbbVie, AIMA/SOPHIE, CanSAGE, CIHR, Endometriosis Australia, Hamilton Health Sciences, Health Canada, Hyivy/MITACS/SOPHIE, Medical Research Future Fund/Imagendo, Myant Inc/MITACS, GE HealthCare/MITACS, and Pfizer; honoraria for lectures/writing from AIUM, AbbVie, Bayer, Canon, GE Healthcare, Pfizer, Samsung, TerSera; consultancy work with AbbVie, Chugai, Gesynta, Hologic, Imagendo, Pfizer, and Roche Diagnostics; and affiliations with SUGO (Specialized Ultrasound in Gynecology & Obstetrics) and Endometriosis360. He holds leadership roles in the World Endometriosis Society Early Career Board, ISUOG Next Generation, and the Gynecologic Ultrasound Society, all outside the submitted work.

E9. Unpacking RANZCOG's Early Pregnancy Screening and Prevention of Preterm Preeclampsia Guideline (video)

Preeclampsia is an uncommon yet high-risk condition – especially when it develops early in pregnancy. In this episode of Talking O&G: A RANZCOG Podcast, host Associate Professor Scott White is joined by Professor Amanda Henry and Associate Professor Daniel Rolnik to unpack RANZCOG’s Early Pregnancy Screening and Prevention of Preterm Preeclampsia Guideline.

This discussion explores the rationale behind the guideline update, how first-trimester screening improves detection of preeclampsia and practical steps for clinicians. Topics include individualised risk assessment, the Fetal Medicine Foundation (FMF) first-trimester algorithm and the use of aspirin for risk reduction. The guests also discuss equity and access, including barriers faced in rural/remote settings, out-of-pocket costs and culturally competent care for First Nations and Māori patients.

🔗Resources mentioned in this episode:

• Early pregnancy screening and prevention of preterm preeclampsia and related complications (C-Obs 61)
• SOMANZ Hypertension in Pregnancy Guideline 2023
• FMF Assessment of risk for Preeclampsia (PE)
  

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E9. Unpacking RANZCOG's Early Pregnancy Screening and Prevention of Preterm Preeclampsia Guideline (audio)

Preeclampsia is an uncommon yet high-risk condition – especially when it develops early in pregnancy. In this episode of Talking O&G: A RANZCOG Podcast, host Associate Professor Scott White is joined by Professor Amanda Henry and Associate Professor Daniel Rolnik to unpack RANZCOG’s Early Pregnancy Screening and Prevention of Preterm Preeclampsia Guideline.

This discussion explores the rationale behind the guideline update, how first-trimester screening improves detection of preeclampsia and practical steps for clinicians. Topics include individualised risk assessment, the Fetal Medicine Foundation (FMF) first-trimester algorithm and the use of aspirin for risk reduction. The guests also discuss equity and access, including barriers faced in rural/remote settings, out-of-pocket costs and culturally competent care for First Nations and Māori patients.

🔗Resources mentioned in this episode:

• Early pregnancy screening and prevention of preterm preeclampsia and related complications (C-Obs 61)
• SOMANZ Hypertension in Pregnancy Guideline 2023
• FMF Assessment of risk for Preeclampsia (PE)
  

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E8. Unpacking RANZCOG's Cervical Cancer Screening Guideline (audio)

Cervical screening is an essential public health measure in the prevention of cervical cancer, and practice continues to evolve with new evidence and recommendations.

In this episode of Talking O&G: A RANZCOG Podcast, host Dr Nisha Khot is joined by Associate Professor Jared Watts and Dr Anna Clare to unpack RANZCOG’s new Signposting Guideline: Cervical Cancer Screening in Australia and Aotearoa New Zealand.

This discussion covers the rationale for the updated guideline and how it can support clinicians in day-to-day practice. Topics include HPV testing as the primary screening tool, risk-based recommendations, self-collection, and managing higher-risk and immunocompromised groups. The guests also explore approaches to trauma-informed care and guidance for special circumstances such as pregnancy, hysterectomy and non-sexually active patients.

They also highlight the importance of culturally safe care, supporting patients to make informed decisions, and what’s next for cervical screening across Australia.

While this episode focuses on the Australian context, we’ll be dedicating a future episode to cervical screening in Aotearoa New Zealand. 

🔗 Resources mentioned in this episode:

• RANZCOG Cervical Cancer Screening Guideline
• RANZCOG Cervical Cancer Screening in Australia and New Zealand Patient Information Pamphlet
• PREVENT Project

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E8. Unpacking RANZCOG's Cervical Cancer Screening Guideline (video)

Cervical screening is an essential public health measure in the prevention of cervical cancer, and practice continues to evolve with new evidence and recommendations.

In this episode of Talking O&G: A RANZCOG Podcast, host Dr Nisha Khot is joined by Associate Professor Jared Watts and Dr Anna Clare to unpack RANZCOG’s new Signposting Guideline: Cervical Cancer Screening in Australia and Aotearoa New Zealand.

This discussion covers the rationale for the updated guideline and how it can support clinicians in day-to-day practice. Topics include HPV testing as the primary screening tool, risk-based recommendations, self-collection, and managing higher-risk and immunocompromised groups. The guests also explore approaches to trauma-informed care and guidance for special circumstances such as pregnancy, hysterectomy and non-sexually active patients.

They also highlight the importance of culturally safe care, supporting patients to make informed decisions, and what’s next for cervical screening across Australia.

While this episode focuses on the Australian context, we’ll be dedicating a future episode to cervical screening in Aotearoa New Zealand. 

🔗 Resources mentioned in this episode:

• RANZCOG Cervical Cancer Screening Guideline
• RANZCOG Cervical Cancer Screening in Australia and New Zealand Patient Information Pamphlet
• PREVENT Project

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E7. Unpacking Intrahepatic Cholestasis of Pregnancy (video)

Intrahepatic cholestasis of pregnancy (ICP) is the most common liver condition due to pregnancy, yet one that still generates a lot of clinical uncertainty. In this episode, host Dr Nisha Khot speaks with experts, Professor Bill Hague, obstetric physician, and Associate Professor Scott White, obstetrician and maternal fetal medicine specialist. Together they delve into the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) Consensus Statement on Diagnosis and Management of ICP, released in 2023, with the Executive Summary published in ANZJOG.

The discussion covers everything from presentation and diagnosis of ICP, management approaches and counselling, the role of ursodeoxycholic acid and alternatives, to timing of birth, monitoring and surveillance, and common misconceptions.

 

🔗 Resources mentioned in this episode:

ANZJOG 2023 – White – Intrahepatic Cholestasis of Pregnancy Contemporary Management

Intrahepatic Cholestasis of Pregnancy – Diagnosis and Management

 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

 

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

 

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E7. Unpacking Intrahepatic Cholestasis of Pregnancy (audio)

Intrahepatic cholestasis of pregnancy (ICP) is the most common liver condition due to pregnancy, yet one that still generates a lot of clinical uncertainty. In this episode, host Dr Nisha Khot speaks with experts, Professor Bill Hague, obstetric physician, and Associate Professor Scott White, obstetrician and maternal fetal medicine specialist. Together they delve into the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) Consensus Statement on Diagnosis and Management of ICP, released in 2023, with the Executive Summary published in ANZJOG.

The discussion covers everything from presentation and diagnosis of ICP, management approaches and counselling, the role of ursodeoxycholic acid and alternatives, to timing of birth, monitoring and surveillance, and common misconceptions.

 

🔗 Resources mentioned in this episode:

ANZJOG 2023 – White – Intrahepatic Cholestasis of Pregnancy Contemporary Management

Intrahepatic Cholestasis of Pregnancy – Diagnosis and Management

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

 

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).